People with metabolic syndrome may have elevated risk for breast cancer mortality, and immunotherapy keeps lung cancer at bay even after discontinuing treatment.

by Thomas Celona

Gaps in goals-of-care discussions may harm young adults with cancer, and 1 in 6 participants in phase II trials get treatments that are eventually approved by the FDA.

by Marci A. Landsmann

NIH layoffs delay research benefiting cancer patients, and celebrity cancer news is often missing important information.

by Kevin McLaughlin

Some early-stage breast cancer patients may not need surgery, and FDA approves Imfinzi for muscle-invasive bladder cancer.

by Eric Fitzsimmons

New prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.

by Thomas Celona

Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.

by Marci A. Landsmann

Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.

by Kevin McLaughlin

HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.

by Thomas Celona

Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.

by Eric Fitzsimmons

Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.

by Marci A. Landsmann